z-logo
Premium
Risk of cancer in the rectal remnant after ileorectal anastomosis in patients with familial adenomatous polyposis: S ingle center experience
Author(s) -
Maehata Yuji,
Esaki Motohiro,
Nakamura Shotaro,
Hirahashi Minako,
Ueki Takashi,
Iida Mitsuo,
Kitazono Takanari,
Matsumoto Takayuki
Publication year - 2015
Publication title -
digestive endoscopy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.5
H-Index - 56
eISSN - 1443-1661
pISSN - 0915-5635
DOI - 10.1111/den.12414
Subject(s) - medicine , colorectal cancer , familial adenomatous polyposis , colectomy , risk factor , gastroenterology , incidence (geometry) , cancer , anastomosis , stage (stratigraphy) , adenomatous polyposis coli , surgery , paleontology , physics , optics , biology
Background and Aim We aimed to evaluate the long‐term risk of cancer in the rectal remnant in patients with familial adenomatous polyposis after ileorectal anastomosis. Methods Cumulative incidence and clinicopathological characteristics of cancer in the rectal remnant were retrospectively investigated in 27 patients with familial adenomatous polyposis who had undergone ileorectal anastomosis. Results During the follow‐up period ranging from 3.0 to 35.0 years (median, 21.1 years), cancer in the rectal remnant developed in 10 patients. Cumulative risk of cancer in the rectal remnant 30 years after surgery was 57%. Five patients had metastases and three patients died of cancer in the rectal remnant after proctectomy. There was a trend towards a higher incidence of cancer in the rectal remnant in patients with small‐intestinal adenoma and congenital hypertrophy of the retinal pigment epithelium. Multivariate analysis revealed that the ocular lesion was an independent risk factor associated with cancer in the rectal remnant. Conclusion Subtotal colectomy with ileorectal anastomosis does not seem to be an appropriate prophylactic surgery in patients with familial adenomatous polyposis.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here